Switch Patients From Atenolol to a Better Beta-Blocker

October 2017

The recent atenolol shortage will renew debate about which beta-blocker to choose and how to switch.

Think of this as a good thing. Atenolol hasn't been shown to improve outcomes in hypertension, heart failure, or post-MI.

Use this as an opportunity to get patients on a better beta-blocker.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote